[at MarketWatch] – Expect more Pfizer-type deals in which large American companies buy foreign rivals and move their head quarters outside the United States. Read more on this. Pfizer Inc. (PFE), currently . . . → Read More: Stock Update (NYSE:PFE): CEO: More Pfizer-like inversion deals coming Similar Articles: Stock Update (NYSE:PFE): Clinton bashes Pfizer-Allergan deal, to propose anti-inversion steps Market Update: Pfizer Inc (NYSE:PFE) – Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee – sources Company Update (NYSE:AGN): Pfizer-Allergan deal refocuses market on US tax-inversion rules